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Phosphorylation is a post translational modification which can rapidly regulate
biochemical pathways by altering protein function, and has been associated with
pathogenicity in bacteria. Once engulfed by host macrophages, pathogenic bacteria
are exposed to harsh conditions and must respond rapidly in order to survive. The
causative agent of TB, Mycobacterium tuberculosis, is unusual amongst the bacteria
because it can survive within the host macrophage for decades in a latent state,
demonstrating a remarkable capacity to successfully evade the host immune response.
This ability may be mediated in part by regulatory mechanisms such as ser/thr/tyr
phosphorylation. Mass spectrometry-based proteomics has afforded us the capacity
to identify hundreds of phosphorylation sites in the bacterial proteome, allowing
for comparative phosphoproteomic studies in the mycobacteria. There remains an
urgent need to validate the reported phosphosites, and to elucidate their biological
function in the context of pathogenicity. However, given the sheer number of putative
phosphorylation events in the mycobacterial proteome, and the technical difficulty
of assigning biological function to a phosphorylation event, it will not be trivial
to do so. There are currently six published phosphoproteomic investigations of a
member of mycobacteria. Here, we combine the datasets from these studies in
order to identify commonly detected phosphopeptides and phosphosites in order
to present high confidence candidates for further validation. By applying modern
mass spectrometry-based techniques to improve our understanding of phosphorylation
and other PTMs in pathogenic bacteria, we may identify candidates for therapeutic
intervention.
Keywords: post-translational modification, phosphorylation, mycobacteria, tuberculosis, proteomics,
phosphoproteomics, mass spectrometry, virulence
INTRODUCTION
Proteins are the bioactive molecule in the cell, and contribute to survival, growth, and reproduction
by interacting with each other, and with metabolites, lipids, nucleic acids and carbohydrates, and
catalyzing biological reactions (Nørregaard Jensen, 2004). Protein biosynthesis and degradation
are tightly regulated by complex biochemical systems in response to the changing needs of
the cell. However, there is an additional mechanism which allows cells to respond rapidly and
efficiently to the external and internal conditions. Post translational modification (PTM) by
selective covalent processing of proteins—by proteolytic cleavage or the addition of a modifying
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group—can drastically alter the properties of a protein
(Mann and Jensen, 2003; Mijakovic, 2010; Stülke, 2010).
Post translational modifications add a layer of complexity to
both bacterial and eukaryotic mechanisms of adaptation to the
surrounding environment.
Modern mass spectrometry (MS) has enabled us to perform
high throughput analysis of PTMs. Since modified proteins
usually occur at low abundance, an enrichment process
is typically carried out for a specific PTM prior to MS
analysis (Semanjski and Macek, 2016). This results in increased
resolution, sensitivity and fragmentation (Cain et al., 2014)
and has contributed to the identification and localization of
phosphosites in many species, including pathogenic bacteria.
Once thought to be found only in eukaryotes, the discovery
of Hanks-type family of kinases in bacteria indicates that a
complex bacterial phosphorylation-mediated signaling system
exists (Bakal and Davies, 2000). These serine/threonine protein
kinases (STPKs) add a phosphate group to a serine/threonine,
while BY-kinases add phosphate groups to Tyrosine residues.
PTMs in bacteria have been linked to pathogenicity, virulence,
resistance and persistence, and are vital for survival (Ge and Shan,
2011; Van Els et al., 2014). MS-based phosphoproteomic analysis
has been carried out in a number of bacterial species, including
Bacillus subtilis (Macek et al., 2007), Escherichia coli (Macek et al.,
2008; Soares et al., 2013), Streptococcus pneumonia (Sun et al.,
2009) Listeria monocytogenes (Misra et al., 2011), Acinetobacter
baumanii (Soares et al., 2014), andMycobacterium tuberculosis.
The Role of Phosphorylation in
M. tuberculosis
The bacillusM. tuberculosis is the causative agent of tuberculosis
(TB), a leading global health crisis which has claimed millions of
lives by continuing to evade clinical intervention. This is largely
due to its ability to lay dormant for many years in the body,
resurfacing if the hosts’ immune system becomes compromised
(Gengenbacher and Kaufmann, 2012). When the bacilli enter the
human lung, they are ingested by alveolar macrophage cells of the
human immune system. The macrophages respond by becoming
acidic and exposing the pathogen to lytic enzymes, oxygenated
lipids, fatty acids, and reactive oxygen and nitrogen intermediates
(Schnappinger et al., 2003). In order to survive in the adverse
environment of the macrophage, M. tuberculosis needs to react
swiftly, which is possible through the regulatory mechanisms
afforded by PTMs (Cain et al., 2014). Mycobacterial STPK
phosphorylation has been long associated with pathogenicity
(Sherman and Grundner, 2014), which has driven efforts to
improve our understanding of the role of phosphorylation in
M. tuberculosis (Prisic and Husson, 2014). Currently, there are
six published manuscripts describing the phosphoproteome of
a member of the Mycobacteria—M. tuberculosis H37Rv (Prisic
et al., 2010; Kusebauch et al., 2014), M. smegmatis, and M. bovis
BCG (Nakedi et al., 2015; Zheng et al., 2015), a clinical isolate of
M. tuberculosis Beijing lineage (Fortuin et al., 2015) and a1pknE
deletion mutant strain of M. tuberculosis (Parandhaman et al.,
2014b). While these studies are discussed in more detail below,
a summary of the methods used and relevant results for each of
them is presented in Table 1. A major difficulty in comparing
phosphoproteomic studies is that we cannot compare those
phosphosites that were uniquely identified by each study, because
it is impossible to determine whether that uniqueness is as a result
of biological differences or the stochastic nature of discovery-
driven MS-based proteomics. The only available study in the
mycobacteria where those uniquely detected phosphosites are
comparable is Nakedi et al. (2015), because the study compared
two strains under the same experimental conditions. In this
case, a relevant conclusion drawn by the authors is that the
phosphosite patterns detected inM. smegmatis andM. bovis BCG
are often species specific and these phosphorylation events are
commonly occurring on entirely different peptides.
The identification of PTMs which contribute to the
pathogenicity of M. tuberculosis by enhancing its ability to
survive in the macrophage is of great interest to the medical
community, as these represent attractive candidates for
therapeutic intervention. This review will focus specifically on
the use of MS-based techniques which have been used to identify
phosphorylated proteins in the mycobacteria, with particular
focus on the identification of phosphorylation sites which may
contribute to pathogenicity and are conserved across pathogenic
strains of mycobacteria.
COMPARATIVE PHOSPHOPROTEOMIC
ANALYSIS OF MYCOBACTERIA
Prisic et al. (2010) were the first to present a global view of
the phosphoproteome of M. tuberculosis H37Rv. They used
in-gel tryptic digest to proteolytically prepare samples of H37Rv
lysate grown under conditions of NO stress, oxidative stress,
hypoxia and using glucose, or acetate as a carbon source.
A total of 152 samples were analyzed on an LTQ mass
spectrometer following enrichment for phosphopeptides using
titanium dioxide beads. In this manner, the authors detected
a total of 506 phosphosites on 301 proteins and identified a
dominant motif for M. tuberculosis STPKs, which was validated
using synthetic peptides. This initial investigation reported 40%
Ser: 60% Thr phosphorylation, and no Tyr phospho-sites—at the
time of publication there was no conclusive molecular evidence
for Tyr phosphorylation in M. tuberculosis, although there was
a long-established association between Tyr phosphorylation and
pathogenicity in other bacteria. (Ilan et al., 1999). Kusebauch
et al. (2014) reported Tyr phosphorylation in M. tuberculosis for
the first time, after establishing that the known M. tuberculosis
STPKs have the capacity to phosphorylate Tyr, and then by
carrying out LCMS/MS analysis onM. tuberculosis culture lysate
enriched for phosphopeptides. In this manner, they detected
30 high-confidence Tyr phospho-sites on 17 M. tuberculosis
proteins, contributing to a Ser: Thr: Tyr ratio of 34:62:4%.
Intriguingly, these authors also found an additional 35 Tyr
phosphorylation sites in publically accessible MS data from
previously published proteomic studies ofM. tuberculosis, where
the assumption that there was no Tyr phosphorylation in
M. tuberculosis had led the authors to overlook them. Subsequent
MS based descriptions of the M. tuberculosis phosphoproteome
have identified similar proportions of Tyr phosphorylation sites,
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TABLE 1 | An overview of the methods used and results generated in the six currently available published studies investigating phosphorylation in the
mycobacteria using mass spectrometry.
References Strain/species Fractionation
method
Enrichment
method
# Proteins
identified
# Sites %S %T %Y Major conclusions
Prisic et al., 2010 M. tuberculosis
H37Rv
SDS PAGE Titanium dioxide
beads
301 516 40 60 - A broad range of proteins
are phosphorylated on S/T
residues in M. tuberculosis,
and may contribute to
virulence.
Kusebauch et al.,
2014
M. tuberculosis
H37Rv
None IMAC with
PHOS-select iron
affinity gel (Sigma)
and then
Titan-sphere
Phos-TiO kit (GL
Sciences Inc.)
232 32 64 4 Tyr phosphorylation does
occur in M. tuberculosis, a
Tyr phosphosite of PknB in
is important in regulating
growth and therefore may
affect survival in stress
conditions.
Parandhaman
et al., 2014b
M. tuberculosis
H37Rv,
M.
tuberculosis1PknE
mutant
2D SDS PAGE None 68 N/A N/A N/A N/A Proteins which are affected
by the 1PknE mutation
under NO stress are
hypothesized to contribute
to pathogenicity of
M. tuberculosis.
Nakedi et al., 2015 M. bovis BCG None TiO2 beads 203 289 35 61.6 3.1 Differences between fast
and slow growing
mycobacteria may be
related to phosphorylation,
with the ability to respond
rapidly to stress associated
with metabolic cost and
slow growth.
M. smegmatis None TiO2 beads 76 106 39.47 57.02 3.51
Fortuin et al., 2015 M. tuberculosis
clinical isolate
Strong cation
exchange
TiO2 beads 214 414 38 59 3 Novel phosphorylation
events were identified in this
clinical strain, expanding our
understanding of
phosphorylation in
M. tuberculosis.
Zheng et al., 2015 M. bovis BCG SDS PAGE or
offline ACN
fractionation
TiO2 beads 398 659 39.5 48.7 11.8 Gel-based and gel-free
phosphoproteomic analysis
of M. tuberculosis may
identify new
pharmacological targets for
drug development.
some of which may be of particular importance in establishing
virulence.
Recently, Nakedi et al. (2015) investigated the impact
of protein phosphorylation in growth-related functions
by measuring differential phosphorylation between two
mycobacterial species during exponential growth phase—the
fast growing, non-pathogenic, soil dwelling Mycobacterium
smegmatis and the slow growing, attenuated strain of
Mycobacterium bovis (BCG). BCG had consistently higher
phosphorylation levels, with 289 phosphosites on 203 proteins,
compared to M. smegmatis with 106 phosphosites found on 76
proteins. The phosphoproteins which were uniquely found in
BCG were generally involved in cell growth and stress response.
Even under optimal growth conditions, BCG appears to have
a high level of phosphorylated stress response proteins which
suggests the capability for quick on/off responses to stressors
within the host, which ultimately allows the bacteria to respond
rapidly and survive more effectively. The potential adaptive
advantage for the pathogen may result in a fitness cost of slower
growth. In a follow-up phosphoproteomic study, Zheng et al.
(2015) found 659 phosphosites on 398 proteins in BCG harvested
during stationary phase. The majority (40.1%) of identified
phosphoproteins in this case were involved in regulation of
metabolism. Again, these findings indicate that phosphorylation
plays an important role in the slower metabolism of BCG, which
may ultimately increase the capability for persistence within the
host, and may be beneficial to the bacteria when faced with drug
treatment (Evangelopoulos and McHugh, 2015).
A phosphoproteomic investigation of a hyper-virulent Beijing
strain of M. tuberculosis by Fortuin et al. (2015) reported the
identification of 414 phosphosites on 214 proteins. Of these,
252 were novel phosphosites which had not been identified in
Frontiers in Microbiology | www.frontiersin.org 3 February 2016 | Volume 7 | Article 141
Calder et al. Ser/Thr/Tyr Phosphorylation in the Mycobacteria
TABLE 2 | Previously reported virulence factors in the M. tuberculosis complex which have been identified in more than one phosphoproteomic dataset,
and their putative role in virulence.
Accession Protein names Phosphopeptides/sites Putative role in virulence References
P9WI73 Serine/threonine-protein kinase
PknG
SGPGTQPADAQTATSATVR Unclear, possibly growth and
metabolism
Nguyen et al., 2005
P9WI77 Serine/threonine-protein kinase
PknE
LPVPSTHPVSPGTR MAPK signaling, survival Parandhaman et al., 2014a
P9WI79 Serine/threonine-protein kinase
PknD
WSPGDSATVAGPLAADSR Unclear, plays a role in TB infection
of the CNS
Be et al., 2012
P9WIE5 Catalase-peroxidase (CP)
(Peroxidase/catalase) KatG
DAITSGIEVVWTNTPTK Antioxidant Ng et al., 2004
P9WJB7 Nucleoid-associated protein EspR AHGLPSAAQQK Transcriptional regulation Blasco et al., 2012
P9WMH1 Iron-dependent repressor IdeR MNELVDTTEMYLR Iron dependent regulation Banerjee et al., 2011
I6Y748 Membrane protein DPPTDPNLR Unknown n/a
The commonly detected phosphopeptide is indicated in bold, along with phosphosites that have been confirmed in more than one study.
FIGURE 1 | Summary of GO terms associated with proteins that were detected in more than one phosphoproteomic dataset, shown by (A) biological
process (B) molecular function. GO analysis performed using STRAP 1.5.
previous phosphoproteome research on the H37Rv strain. Since
the capability for complex signaling is directly related to the
number of phosphorylation events, it could be inferred that an
increasing number of phosphorylation events may play a role
in differentiating virulence in different M. tuberculosis strains.
This is supported by findings that a highly virulent, drug resistant
strain of Acinetobacter baumannii has almost double the number
of phosphosites in comparison to the reference strain (Soares
et al., 2014). It is also interesting to note that phosphorylation
may be linked to drug resistance, which is of concern given
the emergence of drug resistant strains of TB (Evangelopoulos
and McHugh, 2015). Although the mechanism by which a
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bacterium might accumulate additional phosphosites is not fully
understood, it is of interest that Fortuin et al. (2015) identified
phosphorylated forms of 9 out of the 11 STPKs encoded by the
M. tuberculosis genome in this hypervirulent Beijing strain (Prisic
and Husson, 2014), while Prisic et al. (2010) only identified four
in H37Rv.
Although our understanding of the specific activity of
Mycobacterial STPKs is largely incomplete, some substrates and
their downstream functions have been associated with specific
kinases (Supplementary Table 1). While mass spectrometry is
capable of identifying hundreds of phospho-substrates, more
laborious methods are necessary to associate these substrates
with their corresponding kinases. The challenges inherent
in mass-spectrometry-based kinase substrate identification are
discussed in more detail by Sherman and Grundner (2014).
Parandhaman et al. (2014b) made use of a 1PknE deletion
mutant ofM. tuberculosis to identify PknE substrates during NO
stress in M. tuberculosis, and identified 68 phosphoproteins by
combining 2D PAGE MS with phospho-serine and phospho-
threonine specific antibodies. The candidate PknE substrates
identified in this manner may play a role in dormancy within
themacrophage, whichmay have implications for virulence, once
again highlighting the importance of phosphorylation in allowing
the bacterium to respond effectively to the host environment.
Given this information, and somewhat surprisingly, there is
evidence that the PknE gene is non-essential for growth of
M. tuberculosis in culture (Sassetti et al., 2003). Indeed, in culture-
based models it seems that only three of the STPKs available to
M. tuberculosis are individually essential for growth: PknA and
PknB (Wehenkel et al., 2008); and PknG, which is essential for
survival of M. tuberculosis within the macrophage. Walburger
et al. (2004) demonstrated that a strain ofM. bovis BCG carrying
an inactivated PknG gene showed no differences in growth or
cell morphology in liquid medium to the wild type, whereas the
mutant was unable to survive when inside a macrophage because
the bacteria were no longer able to prevent lysosomal fusion. In
many pathogenic bacteria, but particularly inM. tuberculosis, we
are increasingly aware of the complexity of the host/pathogen
interaction during disease progression, while being limited to
culture or animal based models in our attempts to understand
it1. The fact that M. tuberculosis has evolved to exist in the
intracellular space is highlighted by the metabolic changes which
are observed in intracellular M. tuberculosis (Lee et al., 2013),
but we have yet to explore the consequences of phosphorylation
for M. tuberculosis in vivo. It is conceivable that intracellular
STPKs have different activity compared to culture-based systems,
and high-throughput phosphoproteomic analysis of intracellular
M. tuberculosis would allow us to better understand the role of
phosphorylation in the host pathogen interaction.
Identifying Functional Phosphosites for
Further Characterization
The aim of discovery-based proteomics has been to catalog as
many proteins as possible in a sample, with the intent being to
better understand a biological condition or response. However,
1MISSING:pmid:22320122. MISSING:pmid:22320122. (2016).
the volumes of data generated in this manner have not necessarily
achieved a deeper understanding of the biological systems in
question. This problem is equally as confounding, if not more
so, in phosphoproteomic investigations, since it is difficult to
attribute biological significance to a discreet phosphorylation
event. Many of the detected phosphorylation events reported
by these large-scale studies require validation before we can
begin to determine their function. To this end, meta-analysis
of the available data may provide some insight for future
investigations. Although the above-mentioned mycobacterial
phosphoproteomic studies were conducted using different MS-
based methodologies, and in different strains of mycobacteria,
there are discreet phosphorylation events that were commonly
observed in several datasets, and are therefore unlikely to be
random. A phosphopeptide which is observed in more than one
study, or across several mycobacterial strains, may therefore be
the best starting point for further investigation inM. tuberculosis.
To this end, here we present a compilation of commonly detected
phosphopeptides/sites which may thus be of use for future
functional phosphoproteomic investigations in the mycobacteria
(Supplementary Table 2).
A total of 194 phosphopeptides representing 148 proteins
were found to be represented by two or more sets of data
according to the available published supplementary information.
To facilitate comparison at the protein level, the peptide
sequences were matched to H37Rv protein identifiers using
the Protein Information Resource (PIR) batch peptide match
tool against the Uniprot H37Rv proteome (Chen et al., 2013).
GO analysis of the proteins corresponding to these shared
phosphopeptides using STRAP 1.5 (Bhatia et al., 2009) revealed
that the associated GO terms relate to broad regulatory functions,
such as the regulation of cell metabolism, cellular processes,
and growth (Figures 1A,B). While this is expected given the
established role of phosphorylation in metabolic regulation in
bacteria (Kochanowski et al., 2015), this is also potentially
noteworthy as we are only beginning to unravel the importance
of metabolic regulation for intracellularM. tuberculosis and how
this relates to virulence (Eisenreich et al., 2010). Of particular
interest are incidences where the more virulent clinical strain
is phosphorylated on a different residue compared to the other
strains, as in the example of the AEASIETPTPVQSQR peptide
of TatA, a Sec-independent protein translocase protein, which
was phosphorylated on T7 and/or T9 in M. bovis BCG and
M. tuberculosis H37Rv but on S4 in the clinical strain. The
functional significance of this difference remains unknown and
should be validated and investigated, particularly in light of the
contribution of the Tat pathway to virulence in M. tuberculosis
(Feltcher et al., 2010). It should be noted that the utility of
GO analysis in mycobacteria is limited by the availability of
GO annotations and other resources such as KEGG pathway
representation, for which coverage is generally poor.
Differential phosphorylation of the STPKs themselves can
alter their enzymatic activity, and is another possible mechanism
for altered pathogenicity in M. tuberculosis (Chopra et al., 2003;
Durán et al., 2005). Supplementary Table 2 highlights that
phosphorylation is commonly detected in PknA, B, D, E, G, and
H in these mycobacteria; however the differences in localized
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phosphosites between the virulent and less virulent strains are
more pronounced in peptides corresponding to PknA, D, and
G. Having already established the importance of PknA (Singh
et al., 2006) and G (Walburger et al., 2004) for survival within
the macrophage, the biological significance of these differences
in phosphorylation and how they contribute virulence should
now be ascertained. Forrellad et al. (2013) published a summary
of the known virulence factors in the M. tuberculosis complex
and their putative contribution to virulence. Cross referencing
their table of results to ours identified proteins which are known
virulence factors which are also commonly detected in these
phosphoproteomic datasets. These proteins and their putative
role in virulence in the M. tuberculosis complex are presented in
Table 2. Included in these are some previouslymentioned STPKs,
as well as the proteins KatG, EspR, and IdeR.
CURRENT STATE OF
PHOSPHOPROTEOMICS
Currently, the mycobacterial phosphoproteome has been
qualitatively described, which has identified many high
confidence phosphosites. However, a complete description of
the phosphoproteome should include quantitative information
for the specific phosphosite in question as well as for the
phosphorylated protein. In addition, most of the available
phosphoproteomic data is for bacterial culture under a single
condition, and yet we recognize that phosphorylation is
dynamic and can change rapidly (Macek et al., 2009). In order
to address this, it is important to incorporate multiple time
points and experimental conditions in future phosphoproteomic
investigations. These objectives are specifically challenging for
mass spectrometry-based proteomics, and despite promising
technological advances the mycobacterial phosphoproteome has
not yet been quantitatively assessed (de la Fuente van Bentem
et al., 2008). There are many available quantitative proteomic
tools which are applicable in bacterial phosphoproteomics,
which have been discussed in detail elsewhere (Jers et al., 2008;
Macek et al., 2009), however, not all of these are suitable for the
mycobacteria. SILAC, for example, has been used successfully to
quantify proteins in the bacterium Bacillus subtilis (Ravikumar
et al., 2014), but is not currently possible in M. tuberculosis
because the available lysine deficient mutants are not viable
for SILAC. Alternative quantitative methods include label-
free quantitation, which has the benefit of cost effectiveness
allowing for multiple time points/conditions to be explored, or
dimethyl labeling, which is a promising alternative to iTRAQ
and other label-based techniques (Lau et al., 2014). iTRAQ
has been successfully used to quantify the phosphorylation
of arginine in B. subtilis (Schmidt et al., 2014), and therefore
is suitable for measuring S/T/Y phosphorylation in bacterial
systems, but is limited by the number of samples that can be
analyzed concurrently and the high cost of the iTRAQ reagents.
Validation of phosphoproteomic data using targeted proteomics
along with specialized analysis software such as Skyline is an
exciting prospect, as these powerful tools have the capability to
validate specific phosphosites as well as providing quantitative
information. The absolute quantitation of modified peptides
is possible through a combination of heavy-labeled AQUA
peptides and selected reaction monitoring (SRM) MS, although
the successful use of this strategy has not yet been reported in
bacteria (Kirkpatrick et al., 2005).
RECOMMENDATIONS FOR FUTURE
RESEARCH
The field of phosphoproteomics would benefit greatly from
an integrated, easily accessible database containing all available
information, which would facilitate meta-analysis of PTMs
between multiple datasets. Furthermore, such a database for all
known PTMs would allow for more in-depth analysis of the
cross-talk between bacterial PTMs and how this may relate to
pathogenicity, which has been discussed in a review by Soufi
et al. (2012). Such a resource could provide a standardized format
for reporting PTMs, as well as the opportunity to automatically
update database accession numbers for modified proteins—
which would in turn facilitate more meaningful comparison
between different species or strains. Significant challenges exist
prior to the development of such a database, including the lack of
standardized reporting in currently published studies. However,
the capacity to detect PTMs using MS will only increase with
improving technology and the interpretation and management
of the data thus generated is therefore crucial if we are to
translate this into meaningful clinical applications. Through
better understanding of the function of regulatory PTMs in M.
tuberculosis, we may reveal the means to control or cure it.
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